These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31177655)

  • 21. Gentamicin alleviates cholestatic liver injury by decreasing gut microbiota-associated bile salt hydrolase activity in rats.
    Ma Y; Wang H; Yang J; Xin M; Wu X
    Eur J Pharmacol; 2023 Jul; 951():175790. PubMed ID: 37179041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
    Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
    Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefit of farnesoid X receptor inhibition in obstructive cholestasis.
    Stedman C; Liddle C; Coulter S; Sonoda J; Alvarez JG; Evans RM; Downes M
    Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11323-8. PubMed ID: 16844773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease.
    Tyc O; Jansen C; Schierwagen R; Uschner FE; Israelsen M; Klein S; Ortiz C; Strassburg CP; Zeuzem S; Gu W; Torres S; Praktiknjo M; Kersting S; Langheinrich M; Nattermann J; Servant F; Arumugam M; Krag A; Lelouvier B; Weismüller TJ; Trebicka J
    Liver Transpl; 2020 Dec; 26(12):1652-1657. PubMed ID: 32885580
    [No Abstract]   [Full Text] [Related]  

  • 25. Hormesis in Cholestatic Liver Disease; Preconditioning with Low Bile Acid Concentrations Protects against Bile Acid-Induced Toxicity.
    Verhaag EM; Buist-Homan M; Koehorst M; Groen AK; Moshage H; Faber KN
    PLoS One; 2016; 11(3):e0149782. PubMed ID: 26950211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholestatic liver (dys)function during sepsis and other critical illnesses.
    Jenniskens M; Langouche L; Vanwijngaerden YM; Mesotten D; Van den Berghe G
    Intensive Care Med; 2016 Jan; 42(1):16-27. PubMed ID: 26392257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal capacity to digest and absorb carbohydrates is maintained in a rat model of cholestasis.
    Los EL; Wolters H; Stellaard F; Kuipers F; Verkade HJ; Rings EH
    Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G615-22. PubMed ID: 17627970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders.
    Fiorucci S; Distrutti E
    Trends Mol Med; 2015 Nov; 21(11):702-714. PubMed ID: 26481828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholestasis, metabolism and biliary lipid secretion during perfusion of rat liver with different bile salts.
    Baumgartner U; Schölmerich J; Leible P; Farthmann EH
    Biochim Biophys Acta; 1992 Apr; 1125(2):142-9. PubMed ID: 1571357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice.
    Hartmann P; Hochrath K; Horvath A; Chen P; Seebauer CT; Llorente C; Wang L; Alnouti Y; Fouts DE; Stärkel P; Loomba R; Coulter S; Liddle C; Yu RT; Ling L; Rossi SJ; DePaoli AM; Downes M; Evans RM; Brenner DA; Schnabl B
    Hepatology; 2018 Jun; 67(6):2150-2166. PubMed ID: 29159825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
    Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
    Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut.
    Ridlon JM; Kang DJ; Hylemon PB; Bajaj JS
    Dig Dis; 2015; 33(3):338-45. PubMed ID: 26045267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice.
    Tang X; Yang Q; Yang F; Gong J; Han H; Yang L; Wang Z
    J Ethnopharmacol; 2016 Dec; 194():63-71. PubMed ID: 27582267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.
    Zollner G; Marschall HU; Wagner M; Trauner M
    Mol Pharm; 2006; 3(3):231-51. PubMed ID: 16749856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early indications of ANIT-induced cholestatic liver injury: Alteration of hepatocyte polarization and bile acid homeostasis.
    Yang T; Mei H; Xu D; Zhou W; Zhu X; Sun L; Huang X; Wang X; Shu T; Liu J; Ding J; Hassan HM; Zhang L; Jiang Z
    Food Chem Toxicol; 2017 Dec; 110():1-12. PubMed ID: 28986171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic targets for cholestatic liver injury.
    Woolbright BL; Jaeschke H
    Expert Opin Ther Targets; 2016; 20(4):463-75. PubMed ID: 26479335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of maternal cholestasis on biliary lipid and bile acid secretion in the infant rat.
    El-Mir MY; Monte MJ; Morales AI; Arevalo M; Serrano MA; Marin JJ
    Hepatology; 1997 Sep; 26(3):527-36. PubMed ID: 9303479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cholestasis and cholestatic liver diseases].
    Poupon R
    Gastroenterol Clin Biol; 2009; 33(8-9):778-88. PubMed ID: 19556086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function.
    Shoda J; Kano M; Oda K; Kamiya J; Nimura Y; Suzuki H; Sugiyama Y; Miyazaki H; Todoroki T; Stengelin S; Kramer W; Matsuzaki Y; Tanaka N
    Am J Gastroenterol; 2001 Dec; 96(12):3368-78. PubMed ID: 11774951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Molecular mechanisms of bile formation and cholestatic diseases].
    Poupon R
    Bull Acad Natl Med; 2003; 187(7):1261-74; discussion 1274-6. PubMed ID: 15146603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.